Skip to main content
OpenTrials
Completed

NCT Number: NCT04135196

A Prospective Study of Human Bone Adaptation Using a Novel in Vivo Loading Model

The purpose of this study is to understand how different types of mechanical forces can influence bone adaptation (and make bones stronger, potentially). Forces acting on bones cause mechanical strain. In small animals, strain magnitude and rate have been shown to stimulate bone adaptation. This study is designed to test the degree to which strain magnitude and rate govern bone adaptation in healthy adult women.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

The study consists of three Aims:

Aim 1: compare the effect on bone structure of mechanical signals with low strain magnitude, high strain magnitude, and control groups over a 12-month prospective period.

Aim 2. Compare the effect on bone structure of mechanical signals with low strain rate, high strain rate, and control groups over a 12-month prospective period.

Aim 3: Examine the effect of withdrawing mechanical signals, by measuring bone structure during the 12 months after the intervention is withdrawn.

The intervention is a voluntary forearm compression task, consisting of leaning onto the palm of the hand to produce a target force.

The primary outcome measure is change in distal radius bone mineral content (BMC).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Age 21-40
  • Body Mass Index [18-29]
  • 9-14 menstrual cycles/year
  • Dual energy X-ray Absorptiometry total radius bone mineral density (BMD) T-score [-2.5-+1]
  • Free of endocrinopathies
  • No known thyroid, vitamin D, or calcium abnormalities

Exclusion criteria

  • Fracture to wrist <5 years ago
  • Wrist Arthritis
  • Injury to the non-dominant elbow or shoulder <5 years ago
  • Diabetes
  • Severe disabling conditions
  • Cancer <5 years ago
  • Metabolic bone disease
  • Androgen, estrogen, progesterone, calcitonin, Selective Estrogen Receptor Modulators, Parathyroid hormone, gonadotropin-releasing hormone or analogs used <6 months ago
  • Corticosteroids <3 months ago
  • Bisphosphonates or fluoride <3 years ago
  • Cardiovascular/pulmonary disease
  • Uncontrolled hypertension
  • Regular Tobacco use
  • Marijuana use >1 time/week
  • Alcohol >4 drinks/day
  • Pregnancy or lactation <2 years ago
  • Plan to become pregnant or donate eggs within 1 year
  • Depot medroxyprogesterone acetate contraceptive <6 months ago
  • Current participation in upper extremity loading sports (gymnastics, tennis, softball, hockey) >2 times/month
  • Low calcium intake (avoiding dairy products without taking calcium supplement)

Treatment and study plan

voluntary forearm loading task

Other

voluntary task, consisting of leaning onto the palm of the hand until a target force is reached. Each loading bout consists of 100 loading cycles, which takes approximately 2 minutes to complete. The task is performed 4 times per week during the intervention period.

Primary outcomes

  1. Change in UD iBMC

    Time frame: baseline and 12 months

    12-month change in ultra-distal integral bone mineral content, measured with quantitative computed tomography (QCT)

Secondary outcomes

  1. Change in UD cBMC

    Time frame: baseline and 12 months

    12-month change in ultra-distal cortical bone mineral content, measured with quantitative computed tomography (QCT)

  2. Change in UD ecBMC

    Time frame: baseline and 12 months

    12-month change in ultra-distal endocortical bone mineral content, measured with quantitative computed tomography (QCT)

  3. Change in UD tBMC

    Time frame: baseline and 12 months

    12-month change in ultra-distal trabecular bone mineral content, measured with quantitative computed tomography (QCT)

  4. Change in UD iBMD

    Time frame: baseline and 12 months

    12-month change in ultra-distal integral volumetric bone mineral density, measured with quantitative computed tomography (QCT)

  5. Change in UD cBMD

    Time frame: baseline and 12 months

    12-month change in ultra-distal cortical volumetric bone mineral density, measured with quantitative computed tomography (QCT)

  6. Change in UD ecBMD

    Time frame: baseline and 12 months

    12-month change in ultra-distal endocortical bone mineral density, measured with quantitative computed tomography (QCT)

  7. Change in UD tBMD

    Time frame: baseline and 12 months

    12-month change in ultra-distal trabecular bone mineral density, measured with quantitative computed tomography (QCT)

  8. Change in UD iBV

    Time frame: baseline and 12 months

    12-month change in ultra-distal integral bone volume, measured with quantitative computed tomography (QCT)

  9. Change in UD cBV

    Time frame: baseline and 12 months

    12-month change in ultra-distal cortical bone volume, measured with quantitative computed tomography (QCT)

  10. Change in UD ecBV

    Time frame: baseline and 12 months

    12-month change in ultra-distal cortical bone volume, measured with quantitative computed tomography (QCT)

  11. Change in UD tBV

    Time frame: baseline and 12 months

    12-month change in ultra-distal trabecular bone volume, measured with quantitative computed tomography (QCT)

  12. Change in Cortical Thickness

    Time frame: measurements repeated at 0, 3, 6, 9, 12, 18, and 24 months from enrollment

    Changes in cortical thickness at 3-month intervals, measured with high resolution peripheral quantitative computed tomography (HRpQCT)

  13. Change in Trabecular BV/TV

    Time frame: measurements repeated at 0, 3, 6, 9, and 12 months from enrollment

    trabecular bone volume fraction expressed as the ratio of bone volume (BV) to total volume (TV) using: (BV/TV). This quantity is measured with high resolution peripheral quantitative computed tomography (HRpQCT). It is expressed as a ratio, ranging from 0 (none of the volume is occupied by bone) to 1 (all of the volume is occupied by bone).

Sponsors and collaborators

Lead sponsor

Worcester Polytechnic Institute

Other

Collaborators

  • Northwestern University

Registry information

Important dates

Study start
2014
Primary completion
2018
Study completion
2019
First posted
Oct 22, 2019
Registry last updated
Oct 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.